InnoCentive is a web-based community matching scientists to relevant R&D challenges posed by companies from around the globe. It provides an online forum enabling companies to crowdsource scientific innovation through financial incentives.
According to Wired magasine,
"Pharmaceutical maker Eli Lilly funded InnoCentive’s launch in 2001 as a way to connect with brainpower outside the company – people who could help develop drugs and speed them to market. From the outset, InnoCentive threw open the doors to other firms eager to access the network’s trove of ad hoc experts. Companies like Boeing, DuPont, and Procter & Gamble now post their most ornery scientific problems on InnoCentive’s Web site; anyone on InnoCentive’s network can take a shot at cracking them.
The companies – or seekers, in InnoCentive parlance – pay solvers anywhere from $10,000 to $100,000 per solution. (They also pay InnoCentive a fee to participate.)"
This organization provides laboratory chemical and microbiological scientists anywhere in the world to utilize their expertise and earn significant cash payments for their successes.
No comments:
Post a Comment